Rheological properties of emulsion of crude oil and water

In the paper the rheological properties of crude oil of White Tiger oil-field (Vietnam) and its emulsion with sea-water, including measurement results and analytical approximation formulae for wide range of pressure, temperature and water concentration, are presented. As it is known, the crude oil of White Tiger oil-field is a high-paraffin and high-viscous oil. At the low temperature (T ≤ 40°C) it behaves as non-Newtonian fluid of Bingham-Shvedov group. Therefore, beside the effective viscosity, the effective dynamic shear stress is also measured and approximated. The rheological properties of crude oil and emulsion of crude oil and water are also measured and approximated for the case when the mixture contains 0.1% chemical reagent ES-3363

Technical manual: Rice straw management towards circular economy and low emission in the Mekong Delta

The document “Technical manual: Rice straw management towards circular economy and low emission in the Mekong Delta” introduces readers to the characteristics of rice straw, the current status of its treatment, and the management process for using rice straw in a circular way to reduce GHG emissions in rice production. This manual will be a handbook for farmers, extension officers, cooperatives, and others who are interested in rice production that is associated with circular greenhouse gas emission reduction

Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review

Knee osteoarthritis is the most popular type of osteoarthritis that causes extreme pain in the elderly. Currently, there is no cure for osteoarthritis. To lessen clinical symptoms, glucosamine was suggested. The primary goal of our systematic review study is to evaluate the effectiveness and safety of glucosamine based on recent studies. Electronic databases such as PubMed, Scopus, and Cochrane were used to assess the randomized controlled trial (RCT). From the beginning through March 2023, the papers were checked, and if they fulfilled the inclusion criteria, they were then examined. The Western Ontario and McMaster Universities Osteoarthritis (WOMAC) and Visual Analog Scale (VAS) scales were considered the main outcome measures. A total of 15 studies were selected. Global pain was significantly decreased in comparison to placebo, as measured by the VAS index, with an overall effect size of standardized mean difference (SMD) of −7.41 ([95% CI] 14.31, 0.51). The WOMAC scale confirmed that pain, stiffness, and physical function had improved, however the effects were insufficient. A statistical update also revealed that there were no reports of serious medication interactions or significant adverse events. To summarize, glucosamine is more effective than a placebo at reducing pain in knee osteoarthritis patients. In long-term treatment, oral glucosamine sulfate 1500 mg/day is believed to be well tolerated

Cost-Effectiveness of Glucosamine in Osteoarthritis Treatment: A Systematic Review

Osteoarthritis (OA) is a chronic condition that most frequently affects older adults. It is currently the most common disability. The cost of treating an aging population places pressure on the healthcare budget. As a result, it is imperative to evaluate medicines’ cost-effectiveness and, accordingly, their influence on health resource allocation. Our study aims to summarize the cost and outcome of utilizing glucosamine in OA treatment. Databases like Medline, Cochrane, and Scopus were searched as part of the identification process up until April 2023. Our primary inclusion criteria centered on the economic evaluation of glucosamine in OA treatments, providing an incremental cost-effectiveness ratio (ICER). The Quality of Health Economic Studies (QHES) instrument was applied to grade the quality of the studies. Seven qualified studies that discussed the cost-effectiveness of glucosamine with or without other formulations were selected. All of them demonstrated that glucosamine was cost-effective. There was an increase in quality-adjusted life years (QALYs) when incorporating glucosamine in conventional care. Moreover, patented crystalline glucosamine sulfate (pCGS) was more cost-effective than the other formulations of glucosamine (OFG). Overall, utilizing pCGS was more beneficial than using OFG in terms both of cost and quality of life